Show
Sort by
-
CAR-T treatment of pediatric AML : a long and winding road
-
The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1
-
- Journal Article
- A1
- open access
The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation
-
Chemotherapy at the wheel of ALL relapse
-
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
-
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma
-
- Conference Paper
- C3
- open access
NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia : a good prognostic subtype identified in a collaborative international study
-
- Conference Paper
- C3
- open access
Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia
-
Results from the Phase I Clinical Studies Evaluating Cyad-01, a First-Generation NKG2D CAR T-Cell Product in Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
-
Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT